Iroven 1 gm Injection

Iroven 1 gm 1000 mg/20 ml Injection সম্পর্কে

Iroven 1 gm 1000 mg/20 ml Injection একটি ইনজেকশন ঔষধ, যার জেনেরিক নাম Ferric Carboxymaltose এবং শক্তি ১০০০ mg/২০ ml। Ferric Carboxymaltose-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Orion Pharma Ltd। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Ferric Carboxymaltose-এর ১৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Ferium Injection 500 mg/10 ml-এর, প্রতি ইউনিট ৳ ৭০০।

Iroven 1 gm 1000 mg/20 ml Injection কী?

Iroven 1 gm is a injection from Orion Pharma Ltd., with the generic name Ferric Carboxymaltose. The active ingredient is Ferric Carboxymaltose, a complex of iron hydroxide and a carbohydrate polymer that releases iron to help replace body iron stores. Iron is needed to make haemoglobin, which carries oxygen in the blood. The doctor decides whether it is suitable and how it should be given.

Iroven 1 gm-এর ব্যবহার

Whether it is suitable for a particular person is decided by the doctor after assessment. Iroven 1 gm is used to treat iron deficiency anaemia in adults. Only a doctor can confirm whether this injection is appropriate for a particular person. Ask your doctor whether it is right for your condition.

Iroven 1 gm কীভাবে ব্যবহার করবেন

Staff watch the person during and after the injection for any reactions. Iroven 1 gm is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Take Iroven 1 gm 1000 mg/20 ml injection by mouth as your doctor tells you. Follow the doctor's instructions about follow-up. The doctor decides the dose and course based on your body weight, your iron needs and your response.

Iroven 1 gm-এর পার্শ্বপ্রতিক্রিয়া

Low blood phosphorus and raised liver enzyme levels have been reported. Serious allergic-type reactions, including anaphylactic reactions, have been reported. Serious allergic-type reactions can occur, which is why it is given where such reactions can be managed. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

সতর্কতা ও নিরাপত্তা

It should not be used by anyone with hypersensitivity to any of its components. People with other medical conditions, or those taking other medicines, should check with the doctor first. It is classified as Pregnancy Category C, so pregnancy and breastfeeding should be discussed with the doctor, who will weigh the potential benefits and risks. Ask your doctor first if you are pregnant, planning pregnancy or breastfeeding, or if you have other health conditions or take other medicines.

সাধারণ প্রশ্ন

What does Iroven 1 gm treat?

Whether it is suitable for a particular person is decided by the doctor after assessment. Iroven 1 gm is used to treat iron deficiency anaemia in adults.

How is Iroven 1 gm used?

Staff watch the person during and after the injection for any reactions. Iroven 1 gm is given as an injection by a healthcare professional.

Can Iroven 1 gm cause side effects?

Low blood phosphorus and raised liver enzyme levels have been reported. Serious allergic-type reactions, including anaphylactic reactions, have been reported.

Can I use Iroven 1 gm in pregnancy or while breastfeeding?

It should not be used by anyone with hypersensitivity to any of its components. People with other medical conditions, or those taking other medicines, should check with the doctor first.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There are no known drug interactions and none well documented.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity to any of its components.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Do not store above 30°C. Do not freeze.

বিকল্প ব্র্যান্ড: Ferric Carboxymaltose

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

সব দেখুন ১৫ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।